Aldurazyme
Links shared publicly online about this topic
FDA Alert: Genzyme Products, Marketed as Cerezyme, Fabrayzme, Myozyme, Aldurazyme, and Thyrogen
drugs.com — “FDA Alert: Genzyme Products, Marketed as Cerezyme, Fabrayzme, Myozyme, Aldurazyme, and Thyrogen” View full resource at drugs.com
Most Recently Shared on November 14, 2009 at 3:51 am By:
FDA Alert - FDA Warns of Potential for Foreign Particle Contamination in Several Genzyme Products - http://bit.ly/4puEJt
Information for Healthcare Professionals - Potential Contamination of Products Manufactured by Genzyme Corporation, Marketed as Cerezyme, Fabrayzme, Myozyme, Aldurazyme, and Thyrogen
fda.gov — “Fda is warning healthcare professionals about the potential for foreign particle contamination of several products manufactured by genzyme corporation that are used to treat rare, serious, and life-threatening diseases.” View full resource at fda.gov
Most Recently Shared on November 13, 2009 at 4:49 pm By:
Chris Morrison Health Communicator
Not good. Genzyme gets tagged by FDA again. this time--particle contamination in some lots of several products http://bit.ly/2W9Oia
FDA warns of particulate contamination of Genzyme injectable products - MPR
empr.com — “The FDA and Genzyme have notified healthcare professionals about the potential for foreign particle contamination of certain lots of Cerezyme (imiglucerase), Fabrazyme (agalsidase beta), Myozyme (alglucosidase alpha), Aldurazyme (laronidase), and Thyrogen (thyrotropin alpha).” View full resource at empr.com
Most Recently Shared on November 13, 2009 at 8:09 pm By:
MPR News: FDA warns of particulate contamination of Genzyme injectable products: The FDA and Genzyme have notified ... http://bit.ly/1Vdhgj
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Drugs.com
Keeping you up to date with the latest medication news, FDA Medwatch alerts and new drug approvals.
-
Chris Morrison
Editor w/ Elsevier Business Intelligence (f.k.a. Windhover/FDC Reports) family of publications
-
MPR
eMPR.com provides up-to-date, concise drug information at the point-of-care.
Advertisement
